SCHEMBL25819053

SCHEMBL25819053

c1ccc(-c2cc(-c3cccc(-c4ccc5c(c4)C4(c6cc7c(cc6-5)oc5ccccc57)C5CC6CC(C5)CC4C6)c3)cc(-c3ccc4ccccc4c3)c2)cc1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 2/20 0.32
PLA2G4A P47712 2/20 0.32
ALDH1A1 P00352 4/20 0.31
HPGD P15428 3/20 0.31
ANO1 Q5XXA6 1/20 0.31
RARB P10826 1/20 0.31
RARG P13631 1/20 0.31
CHRNA1 P02708 1/20 0.31
CHRNG P07510 1/20 0.31
CHRNB1 P11230 1/20 0.31
CHRNB2 P17787 1/20 0.31
SLC6A2 P23975 1/20 0.31
CHRNB4 P30926 1/20 0.31
SLC6A4 P31645 1/20 0.31
CHRNA3 P32297 1/20 0.31
CHRNA4 P43681 1/20 0.31
SLC6A3 Q01959 1/20 0.31
CHRND Q07001 1/20 0.31
MAPT P10636 3/20 0.30
KDM4E B2RXH2 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25817606 0.94 ALDH1A1 (0.32) ALDH1A1HPGDMAPTKDM4EALOX15
SCHEMBL25038163 0.84 PLA2G2A (0.33) PLA2G2APLA2G4AALDH1A1HPGDMAPT
SCHEMBL25818221 0.84 CHRNA1 (0.30) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL24618527 0.83 HTT (0.33) PLA2G2APLA2G4AALDH1A1HPGDMAPT
SCHEMBL24608808 0.82 PLA2G2A (0.32) PLA2G2APLA2G4AALDH1A1HPGDMAPT
SCHEMBL25878391 0.82 PLA2G2A (0.36) PLA2G2APLA2G4AALDH1A1HPGDMAPT
SCHEMBL24622696 0.82 PLA2G2A (0.37) PLA2G2APLA2G4AALDH1A1HPGDMAPT
SCHEMBL25038124 0.82 HTT (0.32) ALDH1A1HPGDMAPTKDM4EKMT2A
SCHEMBL25035862 0.82 MAPT (0.33) ALDH1A1HPGDMAPTKDM4EALOX15
SCHEMBL25614669 0.82 MEN1 (0.32) ALDH1A1HPGDMAPTKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230217825-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-07-06 US disclosed
US-20230217825-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230217825-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME OR10J3, AOC2, EPCAM PLA2G2A 4458/4885PLA2G4A 4682/4885ALDH1A1 489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.